GOP Texas Attorney General Ken Paxton has filed a lawsuit against U.S. pharmaceutical company Eli Lilly, often referred to simply as “Lilly,” for allegedly bribing providers to prescribe its medications.
Read More Texas: AG Paxton files lawsuit accusing pharma company Eli Lilly of bribing providers to prescribe their medications
Current weight-loss methods and popular therapies like Wegovy and Zepbound result in both fat and muscle loss, which could be especially harmful for older patients.
Read More Fat, not muscle: drugmakers in race for next weight-loss breakthrough
A U.S. judge rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk’s popular drugs Ozempic and Wegovy while a legal challenge over drug shortages unfolds.
Read More Ozempic copies restricted after US judge denies injunction
Eli Lilly said its recently approved obesity treatment Zepbound is now available in U.S. pharmacies.
Read More Eli Lilly’s obesity drug now available in U.S. pharmacies